Workflow
业绩预告
icon
Search documents
康斯特预计2025年度归母净利润1.15亿元至1.25亿元,下降0.1%至8.48%
Zhi Tong Cai Jing· 2026-01-29 10:01
康斯特(300445)(300445.SZ)披露2025年度业绩预告,公司预计归属于上市公司股东的净利润1.15亿元 至1.25亿元,同比下降0.10%至8.48%;扣除非经常性损益后的净利润1.08亿元至1.15亿元,同比下降 0.16%至6.24%。 ...
厚普股份:预计2025年度净利润为680万元~1010万元
Mei Ri Jing Ji Xin Wen· 2026-01-29 09:59
Group 1 - The company, Houp Co., expects a net profit attributable to shareholders of 6.8 million to 10.1 million yuan for 2025, marking a turnaround from losses in the previous year [1] - The primary reason for the performance change is the increase in market demand for traditional natural gas refueling due to a decline in LNG prices and growth in LNG vehicle sales, which has boosted the company's revenue and gross profit [1] - The hydrogen energy business has also developed steadily, reinforcing the overall scale of the company [1] Group 2 - The company has been increasing its efforts in marketing network construction and international business expansion, resulting in significant growth in international business revenue [1] - However, the expansion has led to an increase in market development expenses [1]
ST加加:预计2025年归属于上市公司股东的净利润为-1.1亿元至-2亿元
Mei Ri Jing Ji Xin Wen· 2026-01-29 09:58
(记者 王晓波) 每经AI快讯,ST加加1月29日晚间发布业绩预告,预计2025年归属于上市公司股东的净利润为-1.1亿元 至-2亿元,上年同期为-2.43亿元。基本每股收益-0.10元至-0.18元。上年同期归属于上市公司股东的净 利润-24286.68。基本每股收益-0.21元。业绩变动主要原因是,报告期内,公司持续聚焦主业,深化市 场拓展,提升治理水平,使得亏损幅度有所收窄。报告期内,公司积极提升品牌形象,探索新型营销模 式,同时加强费用管控,减少了传统户外广告的投放,线下广告宣传费用较上年同期有所下降。上年度 公司全资子公司加加食品(宁夏)生物科技有限公司相关业务停止,上年计提了存货跌价准备和其他应 收款信用减值损失,本报告期内公司计提存货跌价准备及其他应收款减值准备金额同比减少。综合以上 因素,公司报告期经营业绩较上年同期亏损减少。 每经头条(nbdtoutiao)——水贝黄金平台"杰我睿"兑付危机调查:40倍杠杆对赌,金价越涨平台越 亏!老板自称"还在深圳",投资者:兑付方案本金打两折,无法接受 ...
闽东电力:预计2025年度净利润为4700万元~7000万元,同比下降58.66%~72.24%
Mei Ri Jing Ji Xin Wen· 2026-01-29 09:55
Group 1 - The company, Mindong Electric Power, forecasts a net profit attributable to shareholders of 47 million to 70 million yuan for 2025, representing a year-on-year decline of 58.66% to 72.24% [1] - The basic earnings per share are expected to be between 0.1 yuan and 0.15 yuan [1] - The primary reason for the performance change is the strict implementation of accounting policies, leading to impairment testing of risk assets, which is expected to result in impairment losses on certain assets [1] Group 2 - The fair value change income is anticipated to decrease by 50 million yuan compared to the same period last year, categorized as non-recurring gains and losses [1] - The specific amounts for the impairment losses and related fair value changes will be determined based on the assessment results from the appointed evaluation agency and the audit results from the auditing agency [1]
翔腾新材:预计2025年全年净亏损2700万元—3900万元
南财智讯1月29日电,翔腾新材发布年度业绩预告,预计2025年全年归属于上市公司股东的净利润 为-3900万元—-2700万元;预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为-3950万 元—-2750万元。业绩变动原因说明:1、行业竞争更趋充分,使得公司产品销售收入规模和综合毛利率 承受一定压力,对归属于上市公司股东的净利润产生影响。2、子公司南京翔辉光电新材料有限公司的 光电薄膜器件生产项目厂房及机器设备等长期资产转固,相应成本费用有所增加。3、受汇率波动影 响,本年度公司汇兑损失较去年同期有所增加。 ...
快可电子(301278)披露2025年度业绩预告,1月29日股价下跌2.17%
Sou Hu Cai Jing· 2026-01-29 09:49
Core Viewpoint - The company, Suzhou KuaiKe Photovoltaic Electronics Co., Ltd., is forecasting a significant decline in net profit for the fiscal year 2025, primarily due to pressures in the photovoltaic industry and other adverse factors [1] Financial Performance - The stock price of KuaiKe Electronics (301278) closed at 36.5 yuan on January 29, 2026, down 2.17% from the previous trading day, with a total market capitalization of 3.274 billion yuan [1] - The company anticipates a net profit attributable to shareholders of between 19 million and 23 million yuan for 2025, representing a year-on-year decline of 80.81% to 76.77% [1] - The net profit after excluding non-recurring gains and losses is expected to be between 5 million and 7.5 million yuan, reflecting a year-on-year decrease of 93.97% to 90.96% [1] Factors Influencing Performance - The decline in performance is attributed to several factors, including: - Profit pressures within the photovoltaic industry chain - Decrease in domestic sales prices - Foreign exchange rate impacts on exports - Rising costs of key materials, particularly copper - Increased depreciation and amortization expenses [1] - Non-recurring gains and losses are expected to impact net profit by approximately 15.5 million yuan, mainly from government subsidies and cash management income [1] - The earnings forecast is unaudited, and final figures will be confirmed in the 2025 annual report [1]
海翔药业(002099)披露2025年度业绩预告(更正后),1月29日股价上涨0.94%
Sou Hu Cai Jing· 2026-01-29 09:49
近日,浙江海翔药业股份有限公司发布2025年度业绩预告(更正后),预计2025年度归属于上市公司股 东的净利润为-13,500万元至-9,000万元,扣除非经常性损益后的净利润为-14,200万元至-9,500万元,基 本每股收益为-0.08元至-0.06元。上年同期分别为-33,026.72万元和-34,027.10万元。公司称2025年亏损幅 度收窄,医药板块收入略有下滑,毛利率承压,染料板块盈利能力修复,台州前进公司资产组无商誉减 值迹象。美元兑人民币汇率走低对净利润产生较大负面影响。本次业绩预告未经审计,最终数据以年度 报告为准。 《2025年度业绩预告(更正后)》 《2025年度业绩预告的更正公告》 截至2026年1月29日收盘,海翔药业(002099)报收于6.41元,较前一交易日上涨0.94%,最新总市值为 103.76亿元。该股当日开盘6.22元,最高6.42元,最低6.14元,成交额达1.96亿元,换手率为1.92%。 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 最新公告列表 ...
吉大正元:2025年预计营收3.9 - 4.3亿元,亏损同比收窄
Xin Lang Cai Jing· 2026-01-29 09:45
Core Viewpoint - The company anticipates a revenue of 390 to 430 million yuan for the year 2025, with a net loss attributable to shareholders ranging from 90 to 115 million yuan, indicating a narrowing of losses compared to the previous year [1] Financial Performance - Expected revenue for 2025 is between 390 million and 430 million yuan, compared to 406.67 million yuan in the same period last year [1] - The net loss attributable to shareholders is projected to be between 90 million and 115 million yuan, an improvement from a loss of 138.52 million yuan in the previous year [1] - The net profit after deducting non-recurring items is expected to be a loss of 98 million to 125 million yuan, compared to a loss of 143.44 million yuan last year [1] Factors Influencing Performance - The performance fluctuation is primarily due to intensified industry competition and extended procurement cycles from some clients, leading to project progress not meeting expectations [1] - The company has achieved certain results in strategic transformation and cost reduction, contributing to a year-on-year narrowing of losses [1]
全信股份:预计2025年净利同比增长51.7%-102.27%
中证智能财讯全信股份(300447)1月29日晚间披露2025年度业绩预告,预计2025年归母净利润2700万元至3600万元,同比增长51.7%-102.27%;扣非净利润 预计2600万元至3500万元,同比增长74.24%-134.56%。以1月29日收盘价计算,全信股份目前市盈率(TTM)约为166.31倍-221.74倍,市净率(LF)约2.99 倍,市销率(TTM)约7.67倍。 以本次披露业绩预告均值计算,公司近年市盈率(TTM)图如下所示: 市净率(LF)历史分位(%) 100 ଛି ୨୦ 80 72.64 70 65.2 ୧ ୨୦୧୧ 463 60 50 50-78 40 30 28.92 20 16:41 10 6.04 0 2020-12-37 1 2021-06-30 ' 2027-12-37 ' -022-72-37 2-06-30 123-12-37 16-30 2n~ 公司 -○- 行业均值 制图数据来自恒生聚源数据库 近年来市盈率变化情况 (倍) 2,0000 1g000 0 27x72 40x25 35:47 30x29 30:46 24:42 30°P -1,000 -2, ...
ST得润:预计2025年全年净亏损2500万元—4000万元
Core Viewpoint - ST德润 expects a significant reduction in losses for the year 2025, with a projected net profit attributable to shareholders ranging from -25 million to -40 million yuan, and a net profit excluding non-recurring losses between 28 million and 40 million yuan [1] Group 1: Financial Performance - The company anticipates a substantial reduction in losses compared to the previous year, primarily due to healthy and orderly development of business operations [1] - The company has focused on its core business, strengthened internal management, and increased investment in research and market expansion, leading to continuous growth in revenue and profitability [1] Group 2: Impact of Subsidiary Changes - The former subsidiary MetaSystem S.p.A. will no longer be included in the consolidated financial statements as of the end of 2024, significantly reducing the negative impact on the company's profit levels [1] Group 3: Legal and Regulatory Issues - The company received a notice of administrative penalty from the China Securities Regulatory Commission, which is expected to negatively impact profit levels due to the provision for potential liabilities related to this penalty and ongoing investor lawsuits [1] - The company is actively cooperating with lawyers to respond to lawsuits, but the uncertainty surrounding the litigation process may lead to significant variability in potential compensation amounts [1]